Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

The influence of creatine on brain functioning
  • Home
  • /
  • The influence of creatine on brain functioning
  1. Home /
  2. Archives /
  3. Vol. 61 (2026) /
  4. Health Sciences

The influence of creatine on brain functioning

Authors

  • Dominika Lewandowska Dr. Anna Gostyńska Wolski Hospital Marcina Kasprzaka 17, 01-211 Warsaw https://orcid.org/0009-0002-4153-4634
  • Katarzyna Otrębska Praski Hospital of the Transfiguration of the Lord, al.“Solidarności” 67, 03-401 Warsaw, Poland https://orcid.org/0009-0002-5169-5992
  • Aleksandra Makulec Medical University of Warsaw, Żwirki i Wigury 63A, 02-091 Warsaw, Poland https://orcid.org/0009-0006-9990-7164
  • Natalia Kostecka Grójec District Medical Center Piotra Skargi 10, 05-600 Grójec, Poland https://orcid.org/0009-0009-6090-7484
  • Aleksandra Jóźwik-Szymańska National Medical Institute of the Ministry of the Interior and Administration, Wołoska 137, 02-507 Warsaw, Poland https://orcid.org/0009-0005-7934-976X
  • Laura Mikuła Czerniakowski Hospital Stępińska 19/25, 00-739 Warsaw https://orcid.org/0009-0000-4827-2492
  • Aleksandra Szredzka Dr. Anna Gostyńska Wolski Hospital Marcina Kasprzaka 17, 01-211 Warsaw https://orcid.org/0009-0007-8906-9379
  • Zuzanna Bogdan-Groszyk Czerniakowski Hospital Stępińska 19/25, 00-739 Warsaw https://orcid.org/0009-0000-9211-0482
  • Jan Kucharski Praski Hospital of the Transfiguration of the Lord https://orcid.org/0009-0006-3480-7998

DOI:

https://doi.org/10.12775/QS.2026.61.72930

Keywords

creatine, brain function, cognition, memory, processing speed, neurodegenerative diseases, depression, mood dissorders, mitochondrial function, ATP metabolism, neuroprocetion, supplementation

Abstract

Creatine is a key component of cellular energy metabolism, supporting ATP resynthesis. Increasing attention has been given to its potential effects on brain function, including cognition, mood regulation, and neuroprotection. The aim of this review was to summarize current evidence on the effects of creatine supplementation on brain function, with a focus on cognitive performance, neurodegenerative diseases, and affective disorders. The literature review included randomized controlled trials, clinical and observational studies, as well as experimental research identified in major scientific databases. Creatine acts primarily by enhancing cellular bioenergetics, increasing ATP availability, and supporting mitochondrial function. The evidence suggests modest cognitive benefits, particularly improvements in memory and processing speed, especially under conditions of increased metabolic demand, such as sleep deprivation or cognitive fatigue. In neurodegenerative diseases, findings remain inconsistent—despite promising preclinical data, large clinical trials have not demonstrated significant therapeutic effects. In affective disorders, particularly depression, creatine shows potential as an adjunctive treatment, enhancing the effectiveness of standard therapies. However, in bipolar disorder, supplementation may carry a risk of triggering manic or hypomanic episodes. Overall, creatine supplementation is a biologically plausible, generally safe, and well-tolerated intervention with context-dependent effects on brain function. While it may provide modest cognitive benefits and support the treatment of depression, current evidence does not justify its use as a primary therapy for neurodegenerative diseases. Further large-scale, well-designed studies are needed to clarify its clinical utility in neuropsychiatric conditions.

 

 

References

1. Forbes SC, Cordingley DM, Cornish SM, Gualano B, Roschel H, Ostojic SM, et al.

Effects of Creatine Supplementation on Brain Function and Health. Nutrients. 22 lutego

2022;14(5):921. doi:10.3390/nu14050921 PubMed PMID: 35267907; PubMed Central

PMCID: PMC8912287.

2. Swatko T, Blicharz M, Czubala M, Bartosik-Zielińska D, Blicharz A, Bartosik M. Effects

of creatine supplementation on brain in the healthy population. J Educ Health Sport. 2

maja 2023;13(4):160–5. doi:10.12775/JEHS.2023.13.04.017

3. Béard E, Braissant O. Synthesis and transport of creatine in the CNS: importance for

cerebral functions. J Neurochem. 2010;115(2):297–313. doi:10.1111/j.1471-

4159.2010.06935.x

4. Institute of Medicine (US) Committee on Nutrition T, Erdman J, Oria M, Pillsbury L.

Creatine. W: Nutrition and Traumatic Brain Injury: Improving Acute and Subacute Health

Outcomes in Military Personnel [Internet]. National Academies Press (US); 2011

[cytowane 17 kwietnia 2026]. Dostępne na:

https://www.ncbi.nlm.nih.gov/books/NBK209321/

5. Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R, Collins R, et al.

International Society of Sports Nutrition position stand: safety and efficacy of creatine

supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 13 czerwca

2017;14(1):18. doi:10.1186/s12970-017-0173-z

6. Wallimann T, Tokarska-Schlattner M, Schlattner U. The creatine kinase system and

pleiotropic effects of creatine. Amino Acids. 1 maja 2011;40(5):1271–96.

doi:10.1007/s00726-011-0877-3

7. Kreider RB, Gonzalez DE, Hines K, Gil A, Bonilla DA. Safety of creatine

supplementation: analysis of the prevalence of reported side effects in clinical trials and

adverse event reports. J Int Soc Sports Nutr. 22(Suppl 1):2488937.

doi:10.1080/15502783.2025.2488937 PubMed PMID: 40198156; PubMed Central

PMCID: PMC11983583.

8. Gonzalez DE, Dickerson BL, Hines K, Chun J, Gil A, Forbes SC, et al. Creatine

Supplementation Dose and Duration Are Not Associated with Increased Side Effects: A

Structured Review and Study-Level Dose–Response Analysis of Randomized Controlled

Trials. Sports. kwietnia 2026;14(4):137. doi:10.3390/sports14040137

9. Zhu S, Li M, Figueroa BE, Liu A, Stavrovskaya IG, Pasinelli P, et al. Prophylactic

Creatine Administration Mediates Neuroprotection in Cerebral Ischemia in Mice. J

Neurosci. 30 czerwca 2004;24(26):5909–12. doi:10.1523/JNEUROSCI.1278-04.2004

PubMed PMID: 15229238; PubMed Central PMCID: PMC6729248.

10. Mallik B, Frank CA. Is creatine a CNS neurotransmitter? eLife. 12:e91824.

doi:10.7554/eLife.91824 PubMed PMID: 37843902; PubMed Central PMCID:

PMC10578925.

11. Meftahi GH, Hatef B, Pirzad Jahromi G. Creatine Activity as a Neuromodulator in the

Central Nervous System. Arch Razi Inst. 31 sierpnia 2023;78(4):1169–75.

doi:10.32592/ARI.2023.78.4.1169 PubMed PMID: 38226371; PubMed Central PMCID:

PMC10787915.

12. Bender* A, Auer* DP, Merl T, Reilmann R, Saemann P, Yassouridis A, et al. Creatine

supplementation lowers brain glutamate levels in Huntington’s disease. J Neurol. 1

stycznia 2005;252(1):36–41. doi:10.1007/s00415-005-0595-4

13. Xu C, Bi S, Zhang W, Luo L. The effects of creatine supplementation on cognitive

function in adults: a systematic review and meta-analysis. Front Nutr. 12 lipca 2024;11.

doi:10.3389/fnut.2024.1424972

14. Gordji-Nejad A, Matusch A, Kleedörfer S, Jayeshkumar Patel H, Drzezga A, Elmenhorst

D, et al. Single dose creatine improves cognitive performance and induces changes in

cerebral high energy phosphates during sleep deprivation. Sci Rep. 28 lutego

2024;14(1):4937. doi:10.1038/s41598-024-54249-9

15. Smith AN, Morris JK, Carbuhn AF, Herda TJ, Keller JE, Sullivan DK, et al. Creatine as a

Therapeutic Target in Alzheimer’s Disease. Curr Dev Nutr. 29 września

2023;7(11):102011. doi:10.1016/j.cdnut.2023.102011 PubMed PMID: 37881206;

PubMed Central PMCID: PMC10594571.

16. (PDF) Creatine monohydrate pilot in Alzheimer’s: Feasibility, brain creatine, and

cognition. ResearchGate. 11 marca 2026. doi:10.1002/trc2.70101

17. Kalia LV, Lang AE. Parkinson’s disease. Lancet. 29 sierpnia 2015;386(9996):896–912.

doi:10.1016/S0140-6736(14)61393-3 PubMed PMID: 25904081.

18. Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson

disease. Nat Rev Dis Primer. 23 marca 2017;3:17013. doi:10.1038/nrdp.2017.13 PubMed

PMID: 28332488.

19. Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD)

Investigators. Effect of Creatine Monohydrate on Clinical Progression in Patients With

Parkinson Disease: A Randomized Clinical Trial. JAMA. 10 lutego 2015;313(6):584–93.

doi:10.1001/jama.2015.120

20. Mo JJ, Liu LY, Peng WB, Rao J, Liu Z, Cui LL. The effectiveness of creatine treatment

for Parkinson’s disease: an updated meta-analysis of randomized controlled trials. BMC

Neurol. 2 czerwca 2017;17(1):105. doi:10.1186/s12883-017-0885-3

21. Jurcau A. Molecular Pathophysiological Mechanisms in Huntington’s Disease.

Biomedicines. czerwca 2022;10(6):1432. doi:10.3390/biomedicines10061432

22. Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, et al. The CREST-

E study of creatine for Huntington disease. Neurology. 8 sierpnia 2017;89(6):594–601.

doi:10.1212/WNL.0000000000004209 PubMed PMID: 28701493; PubMed Central

PMCID: PMC5562960.

23. Poletti S, Mazza MG, Benedetti F. Inflammatory mediators in major depression and

bipolar disorder. Transl Psychiatry. 8 czerwca 2024;14(1):247. doi:10.1038/s41398-024-

02921-z

24. Chand SP, Arif H. Depression. W: StatPearls [Internet] [Internet]. StatPearls Publishing;

2023 [cytowane 1 maja 2026]. Dostępne na:

https://www.ncbi.nlm.nih.gov/books/NBK430847/ PubMed PMID: 28613597.

25. Sherpa NN, De Giorgi R, Ostinelli EG, Choudhury A, Dolma T, Dorjee S. Efficacy and

safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in

depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and

exploratory trial in an under-resourced area. Eur Neuropsychopharmacol. 1 stycznia

2025;90:28–35. doi:10.1016/j.euroneuro.2024.10.004

26. A Randomized, Double-Blind Placebo-Controlled Trial of Oral Creatine Monohydrate

Augmentation for Enhanced Response to a Selective Serotonin Reuptake Inhibitor in

Women With Major Depressive Disorder. Am J Psychiatry [Internet]. [cytowane 1 maja

2026]. Dostępne na: https://psychiatryonline.org/doi/10.1176/appi.ajp.2012.12010009

27. Charney AW, Mullins N, Park YJ, Xu J. On the diagnostic and neurobiological origins of

bipolar disorder. Transl Psychiatry. 23 kwietnia 2020;10(1):118. doi:10.1038/s41398-020-

0796-8

28. Toniolo RA, Silva M, Fernandes F de BF, Amaral JA de MS, Dias R da S, Lafer B. A

randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine

monohydrate as adjunctive treatment for bipolar depression. J Neural Transm. 1 lutego

2018;125(2):247–57. doi:10.1007/s00702-017-1817-5

29. Ovid [Internet]. [cytowane 1 maja 2026]. Creatine monohydrate in resistant depression :

Bipolar Disorders. Dostępne na: https://www.ovid.com/journals/bipdi/fulltext/00129219-

200711000-00011~creatine-monohydrate-in-resistant-depression-a-preliminary

Quality in Sport

Downloads

  • PDF

Published

2026-07-05

How to Cite

1.
LEWANDOWSKA, Dominika, KATARZYNA OTRĘBSKA, ALEKSANDRA MAKULEC, NATALIA KOSTECKA, ALEKSANDRA JÓŹWIK-SZYMAŃSKA, LAURA MIKUŁA, ALEKSANDRA SZREDZKA, ZUZANNA BOGDAN-GROSZYK and KUCHARSKI, Jan. The influence of creatine on brain functioning. Quality in Sport. Online. 5 July 2026. Vol. 61, p. 72930. [Accessed 25 July 2026]. DOI 10.12775/QS.2026.61.72930.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 61 (2026)

Section

Health Sciences

License

Copyright (c) 2026 Dominika Lewandowska, Katarzyna Otrębska, Aleksandra Makulec, Natalia Kostecka, Aleksandra Jóźwik-Szymańska, Laura Mikuła, Aleksandra Szredzka, Zuzanna Bogdan-Groszyk, Jan Kucharski

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 187
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

creatine, brain function, cognition, memory, processing speed, neurodegenerative diseases, depression, mood dissorders, mitochondrial function, ATP metabolism, neuroprocetion, supplementation
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop